Arkolith/Insider Trading/TSBX/Form 4

Versant Venture Capital V, L.P.

10% OwnerTurnstone Biologics Corp. (TSBX) · full profile →Form 4 · filed Aug 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2025Tender(U)82K——0
Aug 8, 2025Tender(U)275K——0
Aug 8, 2025Tender(U)91K——0
Aug 8, 2025Tender(U)207K——0
Aug 8, 2025Tender(U)2.7M——0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-107403) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML